| [1] |
Bishop KS, Kao CHJ, Xu Y, Glucina MP, Paterson RRM, et al. 2015. From 2000 years of Ganoderma lucidum to recent developments in nutraceuticals. Phytochemistry 114:56−65 doi: 10.1016/j.phytochem.2015.02.015 |
| [2] |
Guggenheim AG, Wright KM, Zwickey HL. 2014. Immune modulation from five major mushrooms: application to integrative oncology. Integrative Medicine: Clinician’s Journal 13:32−44 |
| [3] |
Chaturvedi VK, Agarwal S, Gupta KK, Ramteke PW, Singh MP. 2018. Medicinal mushroom: boon for therapeutic applications. 3 Biotech 8:334 doi: 10.1007/s13205-018-1358-0 |
| [4] |
Gáper J, Gáperová S, Pristas P, Naplavova K. 2016. Medicinal value and taxonomy of the tinder polypore, Fomes fomentarius (Agaricomycetes): a review. International Journal of Medicinal Mushrooms 18:851−59 doi: 10.1615/IntJMedMushrooms.v18.i10.10 |
| [5] |
El-Ramady H, Abdalla N, Badgar K, Llanaj X, Törős G, et al. 2022. Edible mushrooms for sustainable and healthy human food: Nutritional and medicinal attributes. Sustainability 14:4941 doi: 10.3390/su14094941 |
| [6] |
Cheute VMS, Backes E, Corrêa RCG, Corrêa VG, Bracht A, et al. 2022. The global market for mushrooms, their uses as dietary supplements and associated safety issues. In Edible Fungi: Chemical Composition, Nutrition and Health Effects, eds. Stojković D, Barros L. UK: Royal Society of Chemistry. pp. 383−93. https://doi.org/10.1039/9781839167522 |
| [7] |
Thakur MP. 2014. Present status and future prospects of tropical mushroom cultivation in India: a review. Indian Phytopathology 67:113−25 |
| [8] |
Kalač P. 2013. A review of chemical composition and nutritional value of wild-growing and cultivated mushrooms. Journal of the Science of Food and Agriculture 93:209−18 doi: 10.1002/jsfa.5960 |
| [9] |
Zhong JJ, Xiao JH. 2009. Secondary metabolites from higher fungi: discovery, bioactivity, and bioproduction. In Biotechnology in China I: Advances in Biochemical Engineering/Biotechnology, eds. Zhong JJ, Bai FW, Zhang W. Heidelberg: Springer, Berlin. pp. 79−150. https://doi.org/10.1007/10_2008_26 |
| [10] |
Shirur MA, Shivalingegowda NS, Chandregowda MJ, Rana RK. 2017. Entrepreneurial behaviour and socio economic analysis of mushroom growers in Karnataka. Indian Journal of Agricultural Sciences 6:840−45 |
| [11] |
El-Ramady H, Abdalla N, Fawzy Z, Badgar K, Llanaj X, et al. 2022. Green biotechnology of oyster mushroom (Pleurotus ostreatus L.): A sustainable strategy for myco-remediation and bio-fermentation. Sustainability 14:3667 doi: 10.3390/su14063667 |
| [12] |
Kapahi M. 2018. Recent advances in cultivation of edible mushrooms. In Biology of Macrofungi. Fungal Biology, eds. Singh B, Lallawmsanga, Passari A. Switzerland: Springer, Cham. pp. 275−86. https://doi.org/10.1007/978-3-030-02622-6_13 |
| [13] |
Ganeshpurkar A, Rai G, Jain AP. 2010. Medicinal mushrooms: Towards a new horizon. Pharmacognosy Reviews 4:127−35 doi: 10.4103/0973-7847.70904 |
| [14] |
Keller NP. 2019. Fungal secondary metabolism: regulation, function and drug discovery. Nature Reviews Microbiology 17:167−80 doi: 10.1038/s41579-018-0121-1 |
| [15] |
Lin CH, Sheu GT, Lin YW, Yeh CS, Huang YH, et al. 2010. A new immunomodulatory protein from Ganoderma microsporum inhibits epidermal growth factor mediated migration and invasion in A549 lung cancer cells. Process Biochemistry 45:1537−42 doi: 10.1016/j.procbio.2010.06.006 |
| [16] |
Patel S, Goyal A. 2012. Recent developments in mushrooms as anti-cancer therapeutics: a review. 3 Biotech 2:1−15 doi: 10.1007/s13205-011-0036-2 |
| [17] |
Hutkins RW, Krumbeck JA, Bindels LB, Cani PD, Fahey G Jr, et al. 2016. Prebiotics: Why definitions matter. Current Opinion in Biotechnology 37:1−7 doi: 10.1016/j.copbio.2015.09.001 |
| [18] |
Singdevsachan SK, Auroshree P, Mishra J, Baliyarsingh B, Tayung K, et al. 2016. Mushroom polysaccharides as potential prebiotics with their antitumor and immunomodulating properties: A review. Bioactive Carbohydrates and Dietary Fibre 7:1−4 doi: 10.1016/j.bcdf.2015.11.001 |
| [19] |
Varshney J, Ooi JH, Jayarao BM, Albert I, Fisher J, et al. 2013. White button mushrooms increase microbial diversity and accelerate the resolution of Citrobacter rodentium infection in mice. The Journal of Nutrition 143:526−32 doi: 10.3945/jn.112.171355 |
| [20] |
Meneses ME, Martínez-Carrera D, Torres N, Sánchez-Tapia M, Aguilar-López M, et al. 2016. Hypocholesterolemic properties and prebiotic effects of Mexican Ganoderma lucidum in C57BL/6 mice. PLoS One 11:e0159631 doi: 10.1371/journal.pone.0159631 |
| [21] |
Wasser S. 2002. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Applied Microbiology and Biotechnology 60:258−74 doi: 10.1007/s00253-002-1076-7 |
| [22] |
Firenzuoli F, Gori L, Lombardo G. 2008. The medicinal mushroom Agaricus blazei Murrill: review of literature and pharmaco-toxicological problems. Evidence-Based Complementary and Alternative Medicine 5:3−15 doi: 10.1093/ecam/nem007 |
| [23] |
Zhou XW, Su KQ, Zhang YM. 2012. Applied modern biotechnology for cultivation of Ganoderma and development of their products. Applied Microbiology and Biotechnology 93:941−63 doi: 10.1007/s00253-011-3780-7 |
| [24] |
Bobek P, Ozdín L, Galbavý Š. 1998. Dose- and time-dependent ´hypocholesterolemic effect of oyster mushroom (Pleurotus ostreatus) in rats. Nutrition 14:282−86 doi: 10.1016/S0899-9007(97)00471-1 |
| [25] |
Phan CW, Wong WL, David P, Naidu M, Sabaratnam V. 2012. Pleurotus giganteus (Berk.) Karunarathna & K.D. Hyde: Nutritional value and in vitro neurite outgrowth activity in rat pheochromocytoma cells. BMC Complementary and Alternative Medicine 12:102 doi: 10.1186/1472-6882-12-102 |
| [26] |
Kubo K, Aoki H, Nanba H. 1994. Anti-diabetic activity present in the fruit body of Grifola frondosa (Maitake) I. Biological and Pharmaceutical Bulletin 17:1106−10 doi: 10.1248/bpb.17.1106 |
| [27] |
Kim HM, Kang JS, Kim JY, Park SK, Kim HS, et al. 2010. Evaluation of antidiabetic activity of polysaccharide isolated from Phellinus linteus in non-obese diabetic mouse. International immunopharmacology 10:72−78 doi: 10.1016/j.intimp.2009.09.024 |
| [28] |
Kumar K, Mehra R, Guiné RPF, Lima MJ, Kumar N, et al. 2021. Edible mushrooms: A comprehensive review on bioactive compounds with health benefits and processing aspects. Foods 10:2996 doi: 10.3390/foods10122996 |
| [29] |
Hwang HJ, Kim SW, Lim JM, Joo JH, Kim HO, et al. 2005. Hypoglycemic effect of crude exopolysaccharides produced by a medicinal mushroomPhellinus baumii in streptozotocin-induced diabetic rats. Life Sciences 76:3069−80 doi: 10.1016/j.lfs.2004.12.019 |
| [30] |
Oh TW, Kim YA, Jang WJ, Byeon JI, Ryu CH, et al. 2010. Semipurified fractions from the submerged-culture broth of Agaricus blazei Murill reduce blood glucose levels in streptozotocin-induced diabetic rats. Journal of Agricultural and Food Chemistry 58:4113−19 doi: 10.1021/jf9036672 |
| [31] |
Genestra M. 2007. Oxyl radicals, redox-sensitive signalling cascades and antioxidants. Cellular Signalling 19:1807−19 doi: 10.1016/j.cellsig.2007.04.009 |
| [32] |
Dröge W. 2002. Free radicals in the physiological control of cell function. Review. Physiological Reviews 82:47−95 doi: 10.1152/physrev.00018.2001 |
| [33] |
Halliwell B. 1995. How to characterize an antioxidant: An update. Biochemical Society Symposium 61:73−101 doi: 10.1042/bss0610073 |
| [34] |
Shishodia SK, Shankar J. 2020. Exploration of mycelial proteins from Aspergillus terreus revealed ribosome biogenesis and antioxidant enzymes. Current Proteomics 17:433−45 doi: 10.2174/1570164617666191004163734 |
| [35] |
Shankar J. 2021. Food habit associated mycobiota composition and their impact on human health. Frontiers in Nutrition 8:773577 doi: 10.3389/fnut.2021.773577 |
| [36] |
Falch BH, Espevik T, Ryan L, Stokke BT. 2000. The cytokine stimulating activity of (1→3)-β-D-glucans is dependent on the triple helix conformation. Carbohydrate Research 329:587−96 doi: 10.1016/S0008-6215(00)00222-6 |
| [37] |
Zhang M, Cui SW, Cheung PCK, Wang Q. 2007. Antitumor polysaccharides from mushrooms: a review on their isolation process, structural characteristics and antitumor activity. Trends in Food Science & Technology 18:4−19 doi: 10.1016/j.jpgs.2006.07.013 |
| [38] |
Manach C, Scalbert A, Morand C, Rémésy C, Jiménez L. 2004. Polyphenols: food sources and bioavailability. The American Journal of Clinical Nutrition 79:727−47 doi: 10.1093/ajcn/79.5.727 |
| [39] |
Ferreira ICFR, Barros L, Abreu RMV. 2009. Antioxidants in wild mushrooms. Current Medicinal Chemistry 16:1543−60 doi: 10.2174/092986709787909587 |
| [40] |
Finley JW, Kong AN, Hintze KJ, Jeffery EH, Ji LL, et al. 2011. Antioxidants in foods: State of the science important to the food industry. Journal of Agricultural and Food Chemistry 59:6837−46 doi: 10.1021/jf2013875 |
| [41] |
Scalbert A, Johnson IT, Saltmarsh M. 2005. Polyphenols: antioxidants and beyond. The American Journal of Clinical Nutrition 81:215S−217S doi: 10.1093/ajcn/81.1.215S |
| [42] |
Sies H, Stahl W, Sundquist AR. 1992. Antioxidant functions of vitamins: Vitamins E and C, Beta-Carotene, and other carotenoids. Annals of the New York Academy of Sciences 669:7−20 doi: 10.1111/j.1749-6632.1992.tb17085.x |
| [43] |
Kozarski M, Klaus A, Jakovljevic D, Todorovic N, Vunduk J, et al. 2015. Antioxidants of edible mushrooms. Molecules 20:19489−525 doi: 10.3390/molecules201019489 |
| [44] |
Barros L, Correia DM, Ferreira ICFR, Baptista P, Santos-Buelga C. 2008. Optimization of the determination of tocopherols in Agaricus sp. edible mushrooms by a normal phase liquid chromatographic method. Food Chemistry 110:1046−50 doi: 10.1016/j.foodchem.2008.03.016 |
| [45] |
Chen SY, Ho KJ, Hsieh YJ, Wang LT, Mau JL. 2012. Contents of lovastatin, γ-aminobutyric acid and ergothioneine in mushroom fruiting bodies and mycelia. LWT 47:274−78 doi: 10.1016/j.lwt.2012.01.019 |
| [46] |
Lakshmi B, Tilak JC, Adhikari S, Devasagayam TPA, Janardhanan KK. 2005. Inhibition of lipid peroxidation induced by γ-radiation and AAPH in rat liver and brain mitochondria by mushrooms. Current Science 88:484−88 |
| [47] |
Figueiredo L, Régis WCB. 2017. Medicinal mushrooms in adjuvant cancer therapies: An approach to anticancer effects and presumed mechanisms of action. Nutrire 42:28 doi: 10.1186/s41110-017-0050-1 |
| [48] |
Byerrum RU, Clarke DA, Lucas EH, Ringler RL, Stevens JA, et al. 1957. Tumor inhibitors in Boletus edulis and other Holobasidiomycetes. Antibiot Chemother 7(1):1−4 |
| [49] |
Torkelson CJ, Sweet E, Martzen MR, Sasagawa M, Wenner CA, et al. 2012. hase 1 clinical trial of Trametes versicolor in women with breast cancer. International Scholarly Research Notices 2012:251632 doi: 10.5402/2012/251632 |
| [50] |
Zhao H, Zhang Q, Zhao L, Huang X, Wang J, et al. 2012. Spore powder of Ganoderma lucidum improves cancer-related fatigue in breast cancer patients undergoing endocrine therapy: a pilot clinical trial. Evidence-Based Complementary and Alternative Medicine 2012:809614 doi: 10.1155/2012/809614 |
| [51] |
Deng G, Lin H, Seidman A, Fornier M, D’Andrea G, et al. 2009. A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients. Journal of Cancer Research and Clinical Oncology 135:1215−21 doi: 10.1007/s00432-009-0562-z |
| [52] |
Yamaguchi Y, Miyahara E, Hihara J. 2011. Efficacy and safety of orally administered Lentinula edodes mycelia extract for patients undergoing cancer chemotherapy: a pilot study. The American Journal of Chinese Medicine 39:451−59 doi: 10.1142/S0192415X11008956 |
| [53] |
Panda SK, Sahoo G, Swain SS, Luyten W. 2022. Anticancer activities of mushrooms: a neglected source for drug discovery. Pharmaceuticals 15:176 doi: 10.3390/ph15020176 |
| [54] |
Fortes RC, Recôva VL, Melo AL, Novaes MRCG. 2010. Life quality of postsurgical patients with colorectal cancer after supplemented diet with Agaricus sylvaticus fungus. Nutricion Hospitalaria 25(4):586−96 |
| [55] |
Nakano H, Namatame K, Nemoto H, Motohashi H, Nishiyama K, et al. 1999. A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: effect on prolongation of survival and improvement of quality of life. Kanagawa Lentinan Research Group. Hepato-gastroenterology 46(28):2662−68 |
| [56] |
Grinde B, Hetland G, Johnson E. 2006. Effects on gene expression and viral load of a medicinal extract from Agaricus blazei in patients with chronic hepatitis C infection. International Immunopharmacology 6:1311−14 doi: 10.1016/j.intimp.2006.04.005 |
| [57] |
Chay WY, Tham CK, Toh HC, Lim HY, Tan CK, et al. 2017. Coriolus versicolor (Yunzhi) use as therapy in advanced hepatocellular carcinoma patients with poor liver function or who are unfit for standard therapy. The Journal of Alternative and Complementary Medicine 23:648−52 doi: 10.1089/acm.2016.0136 |
| [58] |
Yang P, Liang M, Zhang Y, Shen B. 2008. Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC. Advances in Therapy 25:787−94 doi: 10.1007/s12325-008-0079-x |
| [59] |
Isoda N, Eguchi Y, Nukaya H, Hosho K, Suga Y, et al. 2009. Clinical efficacy of superfine dispersed lentinan (β-1,3-glucan) in patients with hepatocellular carcinoma. Hepato-gastroenterology 56:437−41 |
| [60] |
Gao Y, Dai X, Chen G, Ye J, Zhou S. 2003. A randomized, placebo-controlled, multicenter study of Ganoderma lucidum (W. Curt. : Fr.) Lloyd (Aphyllophoromycetideae) polysaccharides (Ganopoly®) in patients with advanced lung cancer. International Journal of Medicinal Mushrooms 5:14 doi: 10.1615/interjmedicmush.v5.i4.40 |
| [61] |
Twardowski P, Kanaya N, Frankel P, Synold T, Ruel C, et al. 2015. A phase I trial of mushroom powder in patients with biochemically recurrent prostate cancer: Roles of cytokines and myeloid-derived suppressor cells for Agaricus bisporus–induced prostate-specific antigen responses. Cancer 121:2942−50 doi: 10.1002/cncr.29421 |
| [62] |
Sumiyoshi Y, Hashine K, Kakehi Y, Yoshimura K, Satou T, et al. 2010. Dietary administration of mushroom mycelium extracts in patients with early stage prostate cancers managed expectantly: a phase II study. Japanese Journal of Clinical Oncology 40:967−972 doi: 10.1093/jjco/hyq081 |
| [63] |
deVere White RW, Hackman RM, Soares SE, Beckett LA, Sun B. 2002. Effects of a mushroom mycelium extract on the treatment of prostate cancer. Urology 60:640−44 doi: 10.1016/S0090-4295(02)01856-3 |
| [64] |
Yassin M, Mahajna JA. 2003. Submerged cultured mycelium extracts of higher Basidiomycetes mushrooms selectively inhibit proliferation and induce differentiation of K562 human chronic myelogenous leukemia cells. International Journal of Medicinal Mushrooms 5:16 doi: 10.1615/interjmedicmush.v5.i3.40 |
| [65] |
Wang H, Ng TB, Ooi VEC. 1998. Lectins from mushrooms. Mycological Research 102:897−906 doi: 10.1017/S0953756298006200 |
| [66] |
Brzin J, Rogelj B, Popovic T, Strukelj B, Ritonja A. 2000. Clitocypin, a new type of cysteine proteinase inhibitor from fruit bodies of mushroom Clitocybe nebularis. Journal of Biological Chemistry 275:20104−9 doi: 10.1074/jbc.M001392200 |
| [67] |
Galesa K, Thomas RM, Kidric M, Pain RH. 2004. Clitocypin, a new cysteine proteinase inhibitor, is monomeric:impact on the mechanism of folding. Biochemical and Biophysical Research Communications 324:576−78 doi: 10.1016/j.bbrc.2004.09.092 |
| [68] |
Ohta T, Inoue H, Kusano G, Oshima Y. 1998. Lepiotins A and B, new alkaloids from the mushrooms, Macrolepiota neomastoidea and Chlorophyllum molybdites. Heterocycles 2(47):883−91 |
| [69] |
Zaidman BZ, Yassin M, Mahajna J, Wasser SP. 2005. Medicinal mushroom modulators of molecular targets as cancer therapeutics. Applied Microbiology and Biotechnology 67:453−68 doi: 10.1007/s00253-004-1787-z |
| [70] |
Poucheret P, Fons F, Rapior S. 2006. Biological and pharmacological activity of higher fungi: 20-year retrospective analysis. Cryptogamie, Mycologie 27:311−33 |
| [71] |
Paterson RRM. 2006. Ganoderma – a therapeutic fungal biofactory. Phytochemistry 67:1985−2001 doi: 10.1016/j.phytochem.2006.07.004 |
| [72] |
Moradali MF, Mostafavi H, Ghods S, Hedjaroude GA. 2007. Immunomodulating and anticancer agents in the realm of macromycetes fungi (macrofungi). International Immunopharmacology 7:701−24 doi: 10.1016/j.intimp.2007.01.008 |
| [73] |
Tang W, Liu JW, Zhao WM, Wei DZ, Zhong JJ. 2006. Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondria mediated apoptosis in lung cancer cells. Life Sciences 80:205−11 doi: 10.1016/j.lfs.2006.09.001 |
| [74] |
Lindequist U, Niedermeyer THJ, Jülich WD. 2005. The pharmacological potential of mushrooms. Evidence-based complementary and alternative medicine 2:906016 doi: 10.1093/ecam/neh107 |
| [75] |
Wang M, Zhao R. 2023. A review on nutritional advantages of edible mushrooms and its industrialization development situation in protein meat analogues. Journal of Future Foods 3:1−7 doi: 10.1016/j.jfutfo.2022.09.001 |
| [76] |
Bell V, Silva CRPG, Guina J, Fernandes TH. 2022. Mushrooms as future generation healthy foods. Frontiers in Nutrition 9:1050099 doi: 10.3389/fnut.2022.1050099 |